Identification
Personal identification
- Full name
- Clare Hoskins
Citation names
- Hoskins, Clare
Author identifiers
- Ciência ID
- A312-40D0-337E
- ORCID iD
- 0000-0002-7200-0566
Telephones
- Telephone
-
- (+44) 141 Ext.: 5482796 (Professional)
Addresses
- Technology and Innovation Centre, 99 George Street, G1 1RD, Glasgow, Glasgow, United Kingdom (Professional)
Websites
- https://www.strath.ac.uk/staff/hoskinsclaredr/ (Professional)
Knowledge fields
- Engineering and Technology - Nano-technology
- Exact Sciences - Chemical Sciences - Colloid Chemistry
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English (Mother tongue) |
Education
Degree | Classification | |
---|---|---|
2012/09/01 - 2013/06/30
Concluded
|
PGCert in Teaching and Learning for Higher Education (Postgraduate Certificate)
Keele University, United Kingdom
|
Pass |
2006/10/01 - 2010/03/15
Concluded
|
PhD in Pharmaceutucs (Doctor of Philosophy)
Robert Gordon University, United Kingdom
"The use of Novel Poly(allylamine) Based Amphiphilic Polymers for Drug Delivery
" (THESIS/DISSERTATION)
|
Paa |
2006/10/01 - 2007/06/30
Concluded
|
PG Cert In Research Methods (Postgraduate Certificate)
Robert Gordon University, United Kingdom
|
Pass |
2002/09/01 - 2006/06/30
Concluded
|
Applied Chemistry (Bachelor)
Robert Gordon University, United Kingdom
|
2:1 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2009/12/01 - 2011/10/31 | Postdoc (Research) | University of Dundee, United Kingdom |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2019/11/01 - Current | Associate Professor (University Teacher) | University of Strathclyde, United Kingdom |
2016/04/01 - 2019/10/31 | Associate Professor (University Teacher) | Keele University, United Kingdom |
2011/11/01 - 2016/03/31 | Assistant Professor (University Teacher) | Keele University, United Kingdom |
Projects
Grant
Designation | Funders | |
---|---|---|
2020/02/01 - Current | Magnetic Nanotechnology to Treat Venous Thromboembolism
218671/Z/19/Z
Other
|
UK Research and Innovation
Ongoing
|
2022/03/01 - 2024/02/28 | EPSRC-IRC Hard to Treat Cancers
n/a
Project Partner
|
Engineering and Physical Sciences Research Council
Ongoing
|
2022/01/01 - 2024/01/01 | Multiscale Metrology Suite for Next-Generation Health Nanotechnologies
n/a
CoI
|
Engineering and Physical Sciences Research Council
Ongoing
|
2020/09/01 - 2023/06/30 | Novel nanomedicine for pancreatic cancer
n/a
Principal investigator
|
Carnegie University Trust
Ongoing
|
2020/09/01 - 2022/06/30 | Electrochemical sensing of nanomedicine fate in pancreatic cancer
n/a
Principal investigator
|
Tenovus Cancer Care
Ongoing
|
2021/05/01 - 2022/04/30 | PaNano-MRI: Use of targeted nanoparticles for early detection in pancreatic cancer
n/a
Principal investigator
|
Cancer Research UK
Ongoing
|
2018/05/01 - 2022/04/30 | Chemical study of insect-plant interactions: a contribution to biorational control of crop pests
info:eu-repo/grantAgreement/RCUK/BBSRC/BB2%FR0227552%F1/GB
|
UK Research and Innovation
Ongoing
|
2021/01/11 - 2022/02/28 | Validation of use of femtosecond lasers in the nanotechnology market
n/a
Principal investigator
|
Engineering and Physical Sciences Research Council
Concluded
|
2020/06/01 - 2021/06/30 | Quilts for Cancer
n/a
Principal investigator
|
Royal Society of Chemistry
Ongoing
|
2019/07/01 - 2020/06/30 | Antimicrobial nanoparticle platforms enhancing capacitabine efficacy in pancreatic cancer
JM/JR
Principal investigator
University of Strathclyde, United Kingdom
|
North Staffordshire Medical Institute
Ongoing
|
2015/06/01 - 2017/12/01 | Nanoparticle-induced Hyperthermia as a Novel Therapy for Cutaneous Leishmaniasis’
Other
Keele University, United Kingdom
|
Wellcome Trust
Concluded
|
Outputs
Publications
Journal article |
|
Intellectual property
Patent |
|
Activities
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2022/10/01 - Current | Oxygen sensitive upconversion nanoparticles
Co-supervisor
|
University of Strathclyde, United Kingdom
|
2022/05/01 - Current | Thermo-responsive analogues for nanoparticle precision delivery in pancreatic cancer therapy
Supervisor
|
University of Strathclyde, United Kingdom
|
2022/04/01 - Current | Next generation nano-carriers for pancreatic cancer therapy
Supervisor
|
University of Strathclyde, United Kingdom
|
2022/04/01 - Current | A nano formulation strategy to enhance the therapeutic potential of exogenous
host defence peptides for inflammatory bowel disease and gastrointestinal infections
Co-supervisor
|
Edinburgh Napier University, United Kingdom
|
2021/06/01 - Current | Evaluation of nanotoxicity of nano therapeutics for pancreatic cancer
Supervisor
|
University of Strathclyde, United Kingdom
|
2021/01/01 - Current | Silver hybrid push-pull particles for pancreatic cancer therapy
Supervisor
|
University of Strathclyde, United Kingdom
|
2019/11/01 - Current | Nanoparticle impregnated wafers for wound regeneration
Supervisor
|
University of Strathclyde, United Kingdom
|
2019/06/01 - 2021/06/01 | Use of nanoparticles to improve the therapeutic
index of navitoclax
Co-supervisor
|
Keele University, United Kingdom
|
2019/06/01 - 2021/06/01 | Resorcinarene nanoparticles for drug solubilisation in pancreatic cancer
Co-supervisor
|
Keele University, United Kingdom
|
2018/05 - 2021/05/01 | Hydroxypropylmethacrylamide based thermoresponsive magnetomicelles for controllable drug delivery in pancreatic cancer.
Supervisor
|
Keele University, United Kingdom
|
2018/06/01 - 2020/06/01 | Development of a novel doxorubicin delivery system for pancreatic cancer.
Supervisor
|
Keele University, United Kingdom
|
2018/06/01 - 2020/06/01 | Resorcinarene-drug analogues for drug delivery
Co-supervisor
|
Keele University, United Kingdom
|
2017/06/01 - 2020/06/01 | Use of hybrid iron oxide-silver nanoparticles for thermo-responsive drug delivery in pancreatic cancer
Supervisor
|
Keele University, United Kingdom
|
2018/06/01 - 2019/06/01 | Silver hybrid nanoparticles for pancreatic cancer
Supervisor
|
Keele University, United Kingdom
|
2015/06/01 - 2018/06/01 | The co-administration of anticancer and pro-apoptotic agents as a novel approach in liver cancer therapy.
Supervisor
|
Keele University, United Kingdom
|
2015/06/01 - 2018/06/01 | Synthesis of drug analogues for pancreatic cancer therapy
Co-supervisor
|
Keele University, United Kingdom
|
2013/06/01 - 2017/06/01 | Diels Alder-mediated release of gemcitabine from nanoparticles: developing improved methods for pancreatic cancer drug delivery
Supervisor
|
Keele University, United Kingdom
|
2012/06/01 - 2016/06/01 | Preparation and evaluation of hybrid gold-iron oxide nanoparticles as a multifunctional platform for diagnosis and therapy
of pancreatic cancer
Supervisor
|
Keele University, United Kingdom
|
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2021/09/01 | Pharmaceutics
(Thesis) Main arguer
|
¿ Jamila Al Mahrooqi (PhD)
University of Reading, United Kingdom
|
2021/05/21 | Medicinal chemistry
(Thesis) Main arguer
|
Mattheu Bruist (Master)
Robert Gordon University, United Kingdom
|
2020/08/06 | Polymer chemistry
(Thesis) Main arguer
|
¿ Abdolelah Jaradat (PhD)
University of Nottingham, United Kingdom
|
2020/07/05 | Polymer chemistry
(Thesis) Main arguer
|
¿ Charles Pearce (PhD)
Queen Mary University of London, United Kingdom
|
2020/06/01 | Polymer chemistry
(Thesis) Main arguer
|
¿ Sarah Blackmore (PhD)
University of Liverpool, United Kingdom
|
2020/05/04 | Pharmaceutics
(Thesis) Main arguer
|
¿ Saeed Akkad (PhD)
University of Kent, United Kingdom
|
2020/04/08 | Metal organic frameworks
(Thesis) Main arguer
|
¿ Panagiota Markopoulou (PhD)
University of Glasgow, United Kingdom
|
2020/02/19 | Regenerative medicine
(Thesis) Main arguer
|
¿ William Woods (Master)
Keele University, United Kingdom
|
2019/10/03 | Cancer nanomedicine
(Thesis) Main arguer
|
¿ Rachael Cameron (PhD)
University of Strathclyde, United Kingdom
|
2019/03/02 | Medicinal chemistry
(Thesis) Main arguer
|
¿ Nicholas Omonga (PhD)
University of Salford, United Kingdom
|
2018/09/06 | Pharmaceutics
(Thesis) Main arguer
|
¿ Ovara Abdullah (PhD)
Islamic University of Bahalawapur, Pakistan
|
2018/09/02 | Molecular biology
(Thesis) Arguer
|
¿ Ali Wasif (PhD)
Keele University, United Kingdom
|
2018/05/02 | Cancer nanomedicine
(Thesis) Main arguer
|
¿ Shannon O’Neill (PhD) |
2018/03/23 | Pharmaceutics
(Thesis) Main arguer
|
Peter Stone (PhD)
Aston University, United Kingdom
|
2018/03/17 | Cancer drug discovery
(Thesis) Arguer
|
¿ Mohammed Abo Donia (PhD)
Keele University, United Kingdom
|
2018/02/12 | Cancer molecular biology
(Thesis) Arguer
|
¿ Chloe Gawlick (Master)
Keele University, United Kingdom
|
2018 | Malaria drug discovery
(Thesis) Arguer
|
¿ Hamza Hameed (PhD)
Keele University, United Kingdom
|
2018 | Polymer chemistry
(Thesis) Main arguer
|
¿ Muqdam Ali (PhD)
University of Nottingham, United Kingdom
|
2018 | Pharmaceutics
(Thesis) Main arguer
|
¿ Noorjahan Aibani (PhD)
Ulster University, United Kingdom
|
2017/08/30 | Pharmaceutics
(Thesis) Main arguer
|
¿ Muhammad Rouk Akram (PhD)
Islamic University of Bahalawapur, Pakistan
|
2017/07/09 | Pharmaceutics
(Thesis) Main arguer
|
¿ Mandeep Marwah (PhD)
Aston University, United Kingdom
|
2016/03/13 | Pharmaceutical manufacture
(Thesis) Main arguer
|
¿ Eman Dahmash (PhD)
Aston University, United Kingdom
|
2016/02/11 | Molecular biology
(Thesis) Arguer
|
¿ Michael Rotherham (PhD)
Keele University, United Kingdom
|
2015/10/14 | Regenerative medicine
(Thesis) Arguer
|
¿ Rupert Wright (PhD)
Keele University, United Kingdom
|
Association member
Society Organization name | Role | |
---|---|---|
2006/01/01 - Current | Royal Society of Chemistry: Fellow |
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2019/06/01 - Current | UK and Ireland Controlled Release Society
Member
|
|
2016/01/01 - Current | Royal Society of Chemistry: Chemical Nanosciences and Nanotechnology Interest Group: Secretary
Other
|
Royal Society of Chemistry, United Kingdom |
2021/07/01 - 2024/06/30 | RSC Chemical Nanosciences and Nanotechnology Interest Group Chair
President / Vice-president
|
Conference scientific committee
Conference name | Conference host | |
---|---|---|
2020/09/01 - Current | CONTROLLED RELEASE SOCIETY ANNUAL MEETING 2021 | |
2021/07/01 - 2022/07/15 | CONTROLLED RELEASE SOCIETY ANNUAL MEETING 2022 - Conference Chair |
Distinctions
Award
2021 | Strathclyde Women in Leadership Network Award |
2019 | Emerging Scientist
Academy of Pharmaceutical Sciences, United Kingdom
|
2019 | Researcher Award
North Staffordshire Medical Institute, United Kingdom
|